Ardelyx (ARDX) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.41% |
| Dec 31, 2025 | 25.83% |
| Sep 30, 2025 | 14.99% |
| Jun 30, 2025 | -6.44% |
| Mar 31, 2025 | -9.20% |
| Dec 31, 2024 | 23.11% |
| Sep 30, 2024 | 15.07% |
| Jun 30, 2024 | 6.86% |
| Mar 31, 2024 | -16.00% |
| Dec 31, 2023 | 14.09% |
| Sep 30, 2023 | 4.30% |
| Jun 30, 2023 | 3.82% |
| Mar 31, 2023 | -45.55% |
| Dec 31, 2022 | 24.96% |
| Sep 30, 2022 | -5.28% |
| Jun 30, 2022 | -4.86% |
| Mar 31, 2022 | 0.19% |
| Dec 31, 2021 | -5.94% |
| Sep 30, 2021 | -5.94% |
| Jun 30, 2021 | -6.80% |
| Mar 31, 2021 | -22.30% |
| Dec 31, 2020 | 4.15% |
| Sep 30, 2020 | -6.32% |
| Jun 30, 2020 | 8.78% |
| Mar 31, 2020 | -24.22% |
| Dec 31, 2019 | -18.21% |
| Sep 30, 2019 | -29.13% |
| Jun 30, 2019 | -26.14% |
| Mar 31, 2019 | -69.69% |
| Dec 31, 2018 | -29.73% |
| Sep 30, 2018 | -161.67% |